A literature review was conducted to locate studies that compared different
serum lithium levels in the long-term treatment of patients with bipolar d
isorder and articles about factors that may affect serum lithium levels, Pa
tients with bipolar disorder on long-term treatment with lithium are typica
lly maintained at serum lithium concentrations between 0.6 and 1.0 mEq/L. A
lthough there are individual exceptions, serum lithium levels below 0.6 mEq
/L have been shown in controlled clinical trials to be less effective in pr
eventing relapses than levels within this range, whereas levels much above
1.2 mEq/L can lead to toxicity. Differences in efficacy between levels with
in the accepted range have not been established. However, higher levels are
associated with greater side effects, which can lead to poor compliance. I
nterindividual variation in pharmacokinetics and pharmacodynamics, as well
as such external factors as diet and concomitant medications, can affect se
rum lithium levels.